Oval aims to bring truly patient-centric autoinjector platforms to market.
Founded in 2009 by Matthew Young, Oval takes a different approach, designing from the outside in, ensuring that all patient needs are met. Our team has a wide range of expertise allowing us to deliver the best solutions to partners and patients.
Our business has developed to meet modern quality standards, with a quality system compliant to BS EN 13485:2016, and working to the guidelines and principals from FDA 21 CFR Pt 820, Medical Device Directive 93/42/EEC and ANSI/AAMI HE75.
In December 2016, Oval was acquired by SMC Ltd., a global contract manufacturer of finished medical devices. The combination of Oval’s design and development capability and SMC’s years of experience in global manufacturing of single patient devices ensures a high level of reliability in product performance and a fast route to market.